JnJ forecasts strong 2023 profit on pharma boost Ruchika Sharma26 Jan 2023 7:30 AM GMTBengaluru: Johnson & Johnson on Tuesday forecast annual profit above Wall Street estimates, as strong demand for its drugs such as cancer...
Johnson and Johnson arm to pay USD 9.75 million to resolve kickback allegations Ruchika Sharma21 Jan 2023 7:45 AM GMTThe surgeon and the hospitals in which the procedures were performed did not pay for the products.
Janssen, Global Partners to discontinue Phase 3 Mosaico HIV vaccine trial Ruchika Sharma19 Jan 2023 10:45 AM GMTLeiden: The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, has announced the results of an...
Bombay HC permits Johnson & Johnson to manufacture, sell baby powder Dr. Nandita Mohan14 Jan 2023 11:49 AM GMTThe Bombay High Court on Wednesday quashed two orders passed by the Maharashtra government revoking the license of Johnson & Johnson company to...
Health Bulletin 13/January/2022 Dr. Nandita Mohan13 Jan 2023 11:15 AM GMTHere are the top health news for the day:Resident doctors leave ICU patients to attend birthday party, Mumbai Hospital demands cancellation of...
Bombay High Court relief to Johnson & Johnson, company allowed to manufacture, sell baby powder Ruchika Sharma12 Jan 2023 8:12 AM GMT“The executive cannot use a hammer to kill an ant. Is it always inevitable that when there is a single case of deviation or non-compliance (to...
Johnson and Johnson may eye deals that boost eye care, surgical robots businesses: CEO Joaquin Duato Ruchika Sharma10 Jan 2023 9:13 AM GMTDuato said many of its future deals would likely be small “tuck-in” acquisitions.
Johnson and Johnson consumer health unit Kenvue files for IPO Ruchika Sharma5 Jan 2023 6:45 AM GMTKenvue said J&J will continue to own at least 80.1% of the voting power of the company’s shares upon completion of the offering.
Abiomed now part of Johnson and Johnson Ruchika Sharma26 Dec 2022 8:45 AM GMTNew Brunswick: Johnson & Johnson has announced that the company has completed its acquisition of Abiomed, Inc. is now part of Johnson &...
CDSCO panel opines Johnson and Johnson to submit details of anticancer drug Teclistamab nod in EU, US Roshni Dhar16 Dec 2022 11:50 AM GMTIn response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the...
Health Bulletin 16/December/2022 Dr. Nandita Mohan16 Dec 2022 11:10 AM GMTHere are the top health news for the day:NMC re-invites applications for establishment of new medical colleges, intake increase of MBBS, PG medical...
After Sanofi drops out of Horizon bid, Amgen emerges as frontrunner Ruchika Sharma12 Dec 2022 8:00 AM GMTSanofi said on Sunday that it was no longer in discussions with Horizon and does not intend to make an offer for it.
